Opendata, web and dolomites

LAF-GRAFT

An Investigation into the viability of employing lipoaspirate fluid as a cellular source in the production of small diameter tissue engineered vascular grafts

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 LAF-GRAFT project word cloud

Explore the words cloud of the LAF-GRAFT project. It provides you a very rough idea of what is the project "LAF-GRAFT" about.

human    cells    patent    implanting    fergal    unviable    grafts    levels    laf    cell    cellular    render    cardiovascular    untested    segments    culture    learned    fluid    regarding    clinicians    career    biodegradable    regenerative    viability    professional    revolutionise    source    complementary    royal    university    medicine    technique    function    small    date    vivo    david    tissue    surgeons    promise    true    burden    me    brien    graft    efficient    vascular    prof    fellowship    setting    incorporating    independent    repertoire    capacity    liposuction    lab    animal    pr    treat    tevgs    regulatory    characterisation    college    isolation    scaffold    safer    decrease    model    return    mechanical    act    digestion    clinical    ireland    possess    evolve    tevg    hold    promotes    skills    treatment    investigation    pittsburgh    onto    environment    engineered    disease    diseased    bypass    oject    manipulation    consolidate    morphological    expand    size    manipulated    stability    vorp    interposition    appropriate    scaling    phd    minimally    aspirate    outgoing   

Project "LAF-GRAFT" data sheet

The following table provides information about the project.

Coordinator
ROYAL COLLEGE OF SURGEONS IN IRELAND 

Organization address
address: Saint Stephen's Green 123
city: DUBLIN
postcode: 2
website: www.rcsi.ie

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Total cost 248˙063 €
 EC max contribution 248˙063 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2015
 Funding Scheme MSCA-IF-GF
 Starting year 2016
 Duration (year-month-day) from 2016-09-01   to  2019-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ROYAL COLLEGE OF SURGEONS IN IRELAND IE (DUBLIN) coordinator 248˙063.00
2    UNIVERSITY OF PITTSBURGH US (PITTSBURGH) partner 0.00

Map

Leaflet | Map data © OpenStreetMap contributors, CC-BY-SA, Imagery © Mapbox

 Project objective

Tissue engineered vascular grafts (TEVGs) hold great promise in the field of regenerative medicine and also possess the true potential to revolutionise the way in which clinicians treat the growing burden of cardiovascular disease. Treatment is achieved by incorporating an appropriate cell source onto a biodegradable scaffold and implanting the graft to bypass non-patent vascular segments. However, numerous issues regarding TEVG cell source render the technique unviable in a clinical setting as the cells require high levels of manipulation including digestion, isolation and culture. These issues increase processing costs, decrease cell stability and raise numerous regulatory issues. The use of minimally manipulated liposuction aspirate fluid (LAF) may offer a safer and more efficient cellular source in regenerative TEVGs. However, the capacity of LAF to act as a viable cell source for TEVGs is untested. The aim of this pr oject is to determine the capacity of LAF derived cells to act as a viable cell source for TEVGs. This will be achieved through characterisation of the LAF cells, investigation of the environment that best promotes favourable cellular behaviour, an in vivo study on the viability of the graft to act as a vascular interposition in a small animal model, scaling of the graft to appropriate human size and finally an in vivo study of the grafts ability to function as a vascular bypass in a large animal model. This fellowship will have an outgoing phase to Prof David Vorp’s Lab at the University of Pittsburgh and a return phase to Prof Fergal O’Brien’s Lab at the Royal College of Surgeons in Ireland. Having recently completed my PhD, which focused on the mechanical and morphological characterisation of human diseased vascular tissue, this fellowship will allow me to expand my existing repertoire of research and complementary skills to consolidate and build upon what I have learned to date as I evolve my independent, professional research career.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LAF-GRAFT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LAF-GRAFT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

RealFlex (2019)

Real-time simulator-driver design and manufacturing based on flexible systems

Read More  

TheaTheor (2018)

Theorizing the Production of 'Comedia Nueva': The Process of Play Configuration in Spanish Golden Age Theater

Read More  

MSOPGDM (2019)

Mechanistic studies of prokaryotic genome defense mechanisms

Read More